Crohn's & Colitis Foundation Of America Inc is categorized under Medical Research in Saint Paul, MN .
Crohn's & Colitis Foundation Of America Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Jim Fennell at the company’s branch by writing to 1885 University Avenue West # 355, Saint Paul, Minnesota MN 55104 or by phoning (651) 917-2424. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Crohn's & Colitis Foundation Of America Inc |
| Contact Person: | Jim Fennell |
| Address: | 1885 University Avenue West # 355, Saint Paul, Minnesota 55104 |
| Phone Number: | (651) 917-2424 |
| Website Address: | ccfa.org |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Crohn's & Colitis Foundation Of America Inc was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jim Fennell for inquiries that concern Crohn's & Colitis Foundation Of America Inc by calling the company number (651) 917-2424, as your correspondence is most welcome. Additionally, the physical location of the branch of Crohn's & Colitis Foundation Of America Inc can be found at the coordinates as well as the street address 1885 University Avenue West # 355 in Saint Paul, Minnesota 55104.
For its online presence, you may visit Crohn's & Colitis Foundation Of America Inc’s website at ccfa.org and engage with its social media outlets through on Twitter and on Facebook.